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OBJECTIVE: To determine the metabolic alterations that lead to the neonatal administration of monosodium glutamate (MSG),
which results in arrested growth and obesity.
ANIMALS AND DESIGN: Wistar rats were injected 5 times, every other day, with 4 g of MSG=kg b.w. or with hyperosmotic
saline (controls), within the first 10 days of life, and were studied at the age of 30 days.
RESULTS: Body weight was lower, whereas adipocyte lipid content, cell diameter, surface area and volume were higher in MSG
rats than in controls. Plasma glucose, insulin, NEFA, glycerol and triglyceride levels, and in vitro production of NEFA by lumbar
fat pad pieces incubated under basal conditions or in the presence of epinephrine and epinephrine plus glucose in the media
were lower in MSG than in control rats. In the same fat pad pieces, the conversion of 1-14C-glycerol into fatty acids was always
enhanced and its conversion into glyceride glycerol was enhanced when incubations were carried out in the presence of
epinephrine or glucose. Both the hormone sensitive lipase activity and mRNA expression were lower in adipose tissue from MSG
rats. Besides, the number of insulin receptors, lipid synthesis from U14C glucose, 3H-2-deoxy D-glucose uptake and cellular
GLUT4 translocation index were higher in adipocytes from MSG rats than from the controls.
CONCLUSION: It is proposed that an enhanced insulin sensitivity in 1 month old MSG rats is responsible for the decreased
lipolytic activity and enhanced glucose uptake. In addition, the enhanced lipogenesis and glycerol reutilization seen in their
adipose tissue, disturbs the normal balance between fat depots breakdown and accumulation in favor of the latter.
International Journal of Obesity (2001) 25, 426 – 433
Keywords: monosodium glutamate obesity; lipolysis; hormone sensitive lipase; glycerol; GLUT4
Introduction
Obesity, which is defined as body fat excess, usually develops
slowly as a result of long-term alterations in energy balance.
In general, when food intake exceeds energy expenditure,
the retained energy is deposited as fat. Neonatal administra-
tion of monosodium glutamate (MSG) to rodents destroys
80 – 90% of the arcuate nuclei neurons1,2 and injures other
central structures3 resulting in several neuroendocrine and
metabolic abnormalities, including arrested growth and obe-
sity.3,4 Unlike obesity induced by gold thioglucose or bipi-
peridyl mustard which are associated with hyperphagia,
obesity in neonatal MSG-treated rodents, is not a result of
overeating. In mice, MSG obesity is associated with a dou-
bling of metabolic efficiency,5 secondary to the high level of
corticosterone.6 In MSG-treated rats high levels of corticos-
terone have also been described7,8 and this is probably
related to the central (via sympathetic nervous system) or
directly suppresive effect of glucocorticoids on brown adi-
pose tissue (BAT) activity.9,10 In most types of obese animals,
BAT is in a thermogenically quiescent and relatively atro-
phied state. Recently, reduced GLUT4 in BAT was found in
both 30 and 90 day old MSG-treated rats.11 The inactivity of
BAT results in a deficit in energy expenditure for thermogen-
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esis and it is believed to contribute to the high metabolic
efficiency and obesity of these animals. We have previously
shown that MSG-rats had lower carcass protein and higher
carcass lipid content than controls.12 Exhaustion of lipid
stores was almost complete after 10 days of fasting in control
rats (83% loss), while the MSG rats lost only 45% of their
initial stores, indicating a lower rate of energy expenditure.12
Indeed, adipose tissue preparations from 3 month-old neo-
natally MSG-treated rats showed decreased responsiveness to
lipolytic agents.12,13 Otherwise, 90 day old MSG treated rats
showed increased lipogenesis14 associated with a decreased
GLUT4 content.15 Therefore, the massive accumulation of
adipose tissue in these animals seems to be related to an
imbalance between the signals which control both the final
lipolytic response and the lipogenic activity.
Although under normal conditions the capability of adi-
pose tissue to utilize glycerol is very low16 due to negligible
glycerokinase activity,17,18 the activity of the enzyme has
been shown to be elevated in the adipose tissue of different
forms of genetic obesities,19 which may contribute to an
enhanced capability of the tissue to reesterify the released
fatty acids, and therefore promote net fat accumulation. On
the other hand, hormone sensitive lipase (HSL) is the key
enzyme that controls the break-down of endogenous trigly-
cerides. Conditions like fasting,20 pregnancy 21 and hiberna-
tion22 have been shown to modify the activity of this
enzyme in adipose tissue, therefore contributing to the
respective amount of fat depots.
In an attempt to gain further insights into the develop-
ment of MSG-induced obesity, lumbar adipose tissue cellu-
larity, in vitro lipolysis and glycerol and glucose utilization, as
well as HSL activity and mRNA expression and GLUT4
content in lumbar adipose tissue were studied in 1 month
old neonatally MSG-treated rats, when net fat accumulation
has not yet developed.
Material and methods
Animals
Male offspring Wistar rats were injected 5 times subcuta-
neously, every other day, with 4 g=kg b.w. MSG (monoso-
dium glutamate, from Sigma, USA) or hyperosmotic saline
(1.25 g=kg b.w., controls) within the first 10 days of life. Pups
were weaned on the 21st day of life and kept in plastic cages
of 40 30 18 cm (10 per cage). They were maintained
under controlled light (0700 to 1900 h) and temperature
(231C) conditions and had free access to food and
water. At the 30th day of age, animals were decapitated
and trunk blood was collected in ice-chilled heparinized
tubes. Plasma was separated by centrifugation at 15 000  g
at 4C and kept at 20C until analysis for glycerol,23 NEFA,24
tiglycerides,25 cholesterol26 and insulin by a rat-specific
radioimmunoassay kit (Novo Industry A=S, Copenhagen,
Denmark). Glucose was assayed by a glucose oxidase kit
(Boehringer Mannheim, Mannheim, Germany).
Lipid carcass content
After shaving and removing the gastrointestinal tract, car-
casses were warmed overnight at 45C. Softened carcasses
were then homogenized in a blender and lipids extracted
from 5 g aliquots with petroleum ether and determined
gravimetrically.
In vitro lipolytic activity and glycerol utilization
Pieces of lumbar fat pads (around 10 mg) were placed in
20 ml vials containing 0.5 ml of Krebs – Ringer bicarbonate
(KRB) supplemented with 20 mg=ml of free fatty acids free
bovine serum albumin. 0.5 ml of KRB without bovine albu-
mine but containing 1-14C-glycerol (0.5 mCi, 20 mM) (from
the Radiochemical Center, Amersham, UK) and supplemen-
ted or not with 10 mM D-glucose and=or 0.1 mg epinephrine
bitartrate were pipeted into each vial. They were sealed,
gassed with O2=CO2 (95 : 5) for 5 min and incubated for
90 min at 37C in a Dubnoff metabolic shaker set at
100 cycles=min. The incubation was stopped by placing the
vials on ice. Aliquots of the media were placed in 10% HClO4
in the cold and supernatants were neutralized with saturated
KHCO3 to measure glycerol.
23 Other aliquots of the medium
were used to measure NEFA.24 The tissue pieces were thor-
oughly rinsed with saline and placed in chloroform-metha-
nol (2 : 1, by vol) for lipid extraction27 and fractionation.28
Radioactivity values were normalized by considering
106 dpm the total radioactivity present in each vial at the
onset of the incubations.
Hormone-sensitive lipase mRNA expression and activity
Total cellular RNA was isolated from lumbar fat adipose
tissue by following a single-step acid guanidinium thiocya-
nate-phenol-chloroform extraction method29 and Northern
blot analysis for HSL mRNA levels were done as previously
described.21 HSL activity was measured in infranatants of
adipose tissue samples homogenized at 4C in 3 vol of 0.25 M
sucrose containing 1 mM EDTA, 1 mM dithioerythreitol,
10 mg=ml leupeptin, and 10 mg=ml antipain, at pH 7.4, and
centrifuged at 110 000  g in a Beckman TL-100 centrifuge
for 45 min at 4C, with a phospholipid-stabilized emulsion of
a dioleoylglycerol ether analogue, 1(3)-mono[3H]oleyl-2-O-
oleoylglycerol as substrate.30 Protein was determined
according to the Bradford method.31
Determination of GLUT4 in plasma membranes
Subcellular membrane fractions of lumbar adipose tissue
were prepared as described by Oka et al 32 taking pooled
tissue samples for homogenization, instead of fat cell sus-
pension. To prepare each membrane fraction, lumbar adi-
pose tissue from 4 to 6 rats were homogenized in 7 wt=vol
buffer (10 mM Tris-HCL, 1 mM EDTA and 250 mM sucrose,
pH 7.4) and centrifuged at 3000  g for 15 min. Fat cakes
were discarded, and the infranatant fat-free extract was
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submitted to a second centrifugation at 12000g for 15 min
to precipitate the plasma membrane fraction (PM). Super-
natant was centrifuged at 28 000  g for 15 min and the
resulting supernatant was centrifuged at 146 000  g for
75 min. The final pellet was resuspended and referred to as
the microsomal fraction (M).
Western blotting
A 12 amino acid peptide of GLUT4, synthesized according to
the deduced carboxy-terminal sequence of this glucose trans-
porter (kindly provided by Dr J Utsumi, Toray Basic Research
Laboratory, Fujisawa, Japan), was coupled to key-hole, and
used for the immunization of male New Zealand rabbits.
Serum was collected 2 months after injection and used for
immunoblotting at 1 : 100 dilution. The specificity of anti-
GLUT4 antibody was checked in membrane fractions of
human red blood cells (HRBC) which contain a high con-
centration of GLUT1. No GLUT4 immunoactivity was
detected in the HRBC.
Membrane samples (40 mg protein) were solubilized in
Laemmli’s sample buffer, subjected to SDS-PAGE (10%) and
electrophoretically transferred to nitrocellulose paper. After
blocking with bovine serum albumin, the sheets were incu-
bated with the antiserum raised against GLUT4, with a
subsequent washing and incubation with [125I] protein A
(Amersham Life Sciences). Blot densities were quantified
through the densitometry using imagemaster1 software
(Imagemaster1 1D, Pharmacia Biotech). The GLUT4 translo-
cation index was calculated using the total cellular content
of PM and M GLUT4 following PM100=(PMM).
Isolation and cellularity of adipocytes
The lumbar fat pads were excised and minced, and incubated
for 50 – 55 min in plastic cups with 4 ml of a medium con-
taining Dulbecco’s modified eagle’s medium (DMEM)
(9.6 g=l), 25 mM HEPES, 40 mg=ml BSA, 2.0 mg=ml collage-
nase type II, pH 7.4 at 37C, according to Rodbell.33 Cells
were filtered through a fine nylon mesh and washed three
times with 25 ml of HANKS, 20 mM HEPES, 1% BSA (HANKS-
HEPES-BSA buffer, HHB), pH 7.4 at 37C. They were resus-
pended in the same buffer until a 5% lipocrit was reached,
and their volume and number determined.34
Glucose transport assay
475 ml aliquots of the 5% lipocrit adipocyte suspension were
incubated in a shaking water-bath at 37C for 30 min. A 2-
deoxy-[2,6-3H]-D-glucose (3H-2DG) pulse (25 ml) (0.12 mCi=
tube and 0.1 mM, final concentration) was added at the
end of the 30 min period of pre-incubation and the transport
reaction was interrupted exactly 3 min after centrifuging
200 ml aliquots of the reaction mixture through silicon oil.
The cell pellet on top of the oil was dipped into a scintilation
cocktail for aqueous samples. In a parallel tube, the same
procedure was repeated except that a [1-14C]-L-glucose pulse
(0.1 mCi=tube) was used instead of 3H-2DG, in order to assess
the non-specific uptake.
Insulin receptor number assay35
The isolated adipocytes were washed three times in HHB
buffer, pH 7.8 at 16C, and resuspended to achieve 10% cell
concentration (v : v). Aliquots (450 ml) from this cell suspen-
sion were pipetted into test tubes containing 125I-monoiodo-
A14-insulin (Amersham Co., UK)(10 000 cpm=tube, 25 ml) and
cold insulin (25 ml) in increasing concentrations (0, 25, 50,
100, 250, 1000, 2500, 10 000, 106 nM) and the mixture was
incubated for 3 h at 16C (since at this low temperature the
insulin internalization process is negligible). At the end,
200ml aliquots of the mixture were collected and transferred
to microfuge tubes (400 ml capacity) previously filled with
100ml of silicone oil (Dimethylsilicone fluid, Thomas Scien-
tific, Swedesboro, NJ, USA) and centrifuged for 6 seconds in a
Beckman microfuge E (Beckman Instruments Inc., USA). The
cell pellet on the top of the oil layer was collected and the
incorporated radioactivity measured in a gamma counter
(Abbot). The tube containing 106 nM cold insulin was used
to determine the non-specific radioactive tracer trapping,
which was discounted from the remaining tubes. Scatchard
data analysis was performed to determine the insulin
receptor number and results were normalized per 105 cells.
Glucose oxidation
The isolated adipocytes were first washed and then resus-
pended to a 5% lipocrit (as described above) in KRB buffer,
pH 7.4 at 37C with 10 mg=ml BSA and 2 mM glucose,
previously gassed for 15 min with 95% O2=5% CO2.
[U-14C]-D-glucose oxidation was assayed using a modifi-
cation of the protocol described by Rodbell.33 In brief, 450 ml
aliquots of the 5% lipocrit cell suspension were transferred to
17 100 mm plastic tubes containing 50 ml of D-[U-14C]-
glucose (0.1 mCi=tube and 2.0 mM final concentration). The
vials were gassed with 95% O2=5% CO2, tightly capped, and
incubated for 60 min at 37C in an orbital shaking water-
bath (180 rpm). At the end of the incubation, 150 ml of 8N
H2SO4 was added to the mixture and the
14CO2 released was
collected by adsorption onto a Whatman No. 2 filter paper
previously impregnated with 200 ml ethanolamine and coiled
in a small plastic well fixed on top of the tube. The filter
papers were then transferred to scintillation vials for radio-
activity measurement.
Glucose incorporation into total lipids
After the collection of 14CO2 in the above assay, lipids from
cell lysates were extracted with Dole’s reagent (isopropanol :
heptane 4 : 1 v=v)36 and the heptane fraction of the extracted
lipids was transferred to scintillation vials for determination
of 14C-incorporated.
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Statistical analysis of the data
Results are expressed as means s.e. Analysis of variance was
used to test the significance of the differences between
groups. Where differences were statistically significant,
they were tested by Tukey and Rsquo’s test. Differences
between two groups were analyzed by Student’s unpaired
test.
Results
As shown in Table 1, 30 day old rats given MSG when
neonates showed a significantly lower body weight than
their controls, whereas their percentual fat carcass content
and lumbar fat pad weight did not differ when comparing
the two groups. However, as also shown in Table 1, lipid
content per cell, adipose cell diameter, surface area and
volume appeared significantly higher in MSG rats than in
controls. Otherwise, cell number was lower in MSG rats than
in controls.
As shown in Table 2, plasma glucose, insulin, NEFA,
glycerol and triglyceride concentration were significantly
lower in MSG compared to control rats whereas plasma
cholesterol did not differ between the two groups.
In vitro production of both glycerol and NEFA was studied
in pieces of lumbar fat pads incubated under different con-
ditions. As shown in Table 3, when incubated without
glucose and epinephrine in the medium, the release of
glycerol into the medium presented no difference between
tissues from both control and MSG rats, while the produc-
tion of NEFA was significantly lower in tissues from MSG rats
compared to the controls. Epinephrine significantly
enhanced the production of both glycerol and NEFA in
tissues from both groups incubated in the absence of glucose,
although the increase in NEFA found in the tissues from
MSG rats (92%) was smaller than the one seen in those from
control rats (160%), and the difference between the groups
remained statistically significant. When glucose was present
in the medium, the production of both glycerol and NEFA in
the tissues incubated under basal conditions (that is, in the
absence of epinephrine) was lower than in those studied in
the absence of glucose, and no differences between MSG and
control rats could be detected. In the presence of glucose,
epinephrine enhanced the production of glycerol and NEFA
in tissues from both groups although the effect on NEFA but
not on glycerol was smaller in MSG rats (141%) than in
control rats (303%).
In order to check whether adipose tissue from MSG and
control rats differed in their capability to reutilize the
released glycerol, incubations of pieces from lumbar fat
pads were carried out in the presence of tracer amounts of
1-14C-glycerol and its conversion into tissue lipids was mea-
sured. As shown in Table 4, when incubations were carried
out in the absence of glucose, the appearance of radioactivity
in tissue lipids mainly corresponded to the glyceride glycerol
fraction and did not differ when comparing the control and
MSG rats, although the amount of radioactivity present in
fatty acids was higher in the latter group. In the absence of
Table 1 Body weight, carcass lipid content and white adipose tissue
cellular characteristics from 1 month-old MSG treated-rats
Control MSG
Body weight (g) 95.81.6 72.9 1.5*
Lipid carcass content (%) 12.41.4 14.4 1.1
Fat pad weight (g) 0.250.01 0.23 0.02
Lipid content per cell (ng) 40.41.6 61.3 2.2*
Cell diameter (mm) 43.90.5 50.4 0.6*
Cell surface (mm2) 6056149 7985 180*
Cell volume (pl) 44.41.6 67.3 2.2*
Cell number105=ml 11.31.8 7.4 0.9*
*P<0.001 compared to controls.
n 6 rats=group.
Table 2 Plasma level of metabolites and insulin in 1 month-old MSG-
treated rats
Control MSG
Glucose (mmol=l) 7.40.1 6.3 0.1*
Insulin (pmol=l) 38719 292 9*
NEFA (mM) 28432 173 13*
Glycerol (mM) 2328 114 5*
Triglycerides (mg=dl) 134.011.8 87.5 4.1*
Cholesterol (mg=dl) 87.82.9 90.9 3.7
*P< 0.001 compared to controls.
n6 rats=group.
Table 3 In vitro glycerol and NEFA release by lumbar fat pad pieces from 1 month-old MSG-treated rats
Glucose (5 mM) – –  
Epinephrine (0.5 mg=ml) –  – 
Glycerol (nmol=100 mg) Control 220 30a 376 43b 657c 738 106d
MSG 237 24a 416 42b 6017c 890 60d
P NS NS NS NS
NEFA (nmol=100 mg) Control 415 52a 1078 120b 22027c 886 92b
MSG 257 23a 493 20b 15227c 366 40b
P <0.05 <0.001 NS <0.01
n4 – 6 rats=group.
Superscript letters indicate the statistical comparisons between the different incubation conditions within each group (different
letters P< 0.05) whereas P values correspond to the comparison between the two groups (NSNot significant, P>0.05).
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glucose the presence of epinephrine in the medium greatly
decreased the appearance of radioactivity in tissue total
lipids, the effect being smaller in tissues from MSG rats
(50%) than from controls (71%). Total lipids, fatty acids
and glyceride glycerol showed significant difference between
MSG and controls although nonsaponifiable lipids were not.
In the presence of glucose in the incubation medium but in
the absence of epinephrine, tissues from MSG rats incorpo-
rated more radioactivity in total lipids than control rats, the
effect corresponding to all the lipidic fractions (Table 4). In
the presence of glucose, the addition of epinephrine to the
medium greatly reduced the conversion of labelled glycerol
into tissue lipids, but still under this condition, tissues from
MSG rats showed a higher amount of radioactivity in total
lipids than those from controls, and this effect mainly
corresponded to the label appeared in fatty acids.
As shown in the left part of Figure 1, HSL activity was
significantly lower in the adipose tissue of MSG rats than in
control rats. Northern hybridization techniques were used to
explore the effect on HSL mRNA extracted from lumbar
adipose tissue and the results are illustrated in the right
part of Figure 1. The insert of this figure shows a representa-
tive auto radiogram of the hybridization of the cDNA probe
for HSL mRNA in both experimental groups. Lumbar adipose
tissue from MSG rats showed decreased HSL mRNA in
comparison to control animals.
The adipocyte functionality related to glucose utilization
was evaluated and values are shown in Table 5. When
incubated in the presence of U-14C-glucose both the incor-
poration of 14C into total lipids and into CO2 were signifi-
cantly higher in adipocytes from MSG than from control
rats. The uptake of 3H-2-deoxy-D-glucose was also higher in
adipocytes from MSG than from control rats, whereas plasma
membrane GLUT4 content did not differ in the two groups,
the microsomal GLUT4 content was higher in controls than
in MSG rats, also causing a higher GLUT4 translocation
index in the latter. The amount of insulin receptors in
adipocytes from 1 month-old MSG rats was significatly
higher (4.920.63 fm=105, n6) than that from control
rats (1.760.09, n6, P<0.001).
Discussion
The present study shows that already at the age of 30 days
neonatally MSG-treated rats weigh less than control rats,
which agrees with the information found in previous
reports,13,37 but percentual carcass lipid content remains
constant. This finding also agrees with the fact that mice
neonatally injected with MSG do not become obese until
puberty.4 Decreased body weight in these animals may be
associated to decreased growth hormone (GH) levels, which
was previously found in 30 day old MSG-treated rats.38,39
Decreased plasma levels of both NEFA and glycerol as well
as decreased adipose tissue lipolysis and HSL activity found
in our MSG-treated rats also support such decreased GH
levels, since these changes have been reported to occur in
GH deficient conditions in adults.40
However, adipose tissue cellularity shows that adipocytes
in our 1 month old MSG-rats are already enlarged, indicating
that they are initiating the development of obesity of the
hypertrophic type, as has also been shown to occur in MSG-
treated mice.41 The present findings also show that at this
early stage of development, the adipose tissue of the MSG-
rats is already greatly functionally modified. Adipose tissue
lipolytic activity is clearly decreased in these animals, as
shown by the decreased in vitro release of NEFA under basal
and epinephrine-stimulated conditions, the low activity and
mRNA expression of HSL seen in this tissue as well as the
Table 4 Tissue radioactivity in pieces of lumbar adipose tissue from 1 month-old MSG-treated rats incubated in vitro in the presence of
1-14C-glycerol
Corrected DPM=100 mg tissue
Glucose (5 mM) – –  
Epinephrine (0.1 mg=ml) –  – 
Control 23537543734a 691066943b 12186119694c 41272 2921d
Total Lipid MSG 20695643396a 974835314b 20540612494a 65067 7218d
P NS < 0.01 < 0.01 < 0.01
Control 2310610a 597265b 423996565c 7139 1259b
Fatty acids MSG 4503163a 3106113b 67573688c 18805 4087d
P <0.01 <0.001 < 0.01 < 0.05
Control 94943a 83125b 94349a 521 20c
Nonsaponifiable Lipids MSG 91827a 81328b 2405307c 761 14b
P NS NS < 0.001 <0.001
Control 22871145193a 663056576b 7456810320b 30239 3898c
Glyceride-glycerol MSG 19498536821a 974456076b 13542818655a 45501 9928c
P NS < 0.01 < 0.05 NS
n4 – 6 rats=group.
Superscript letters indicate the statistical comparisons between the different incubation conditions within each group (different letters P<0.05)
whereas P values correspond to the comparison between the two groups (NSNot significant, P>0.05).
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decreased plasma NEFA and glycerol levels. A decreased
availability of lipolytic products to the liver could also
explain the decreased plasma triglyceride levels found in
the 1 month old MSG-rats. This is the first time that such
decreased adipose tissue lipolytic activity is reported in these
animals, and although this change contrasts with the
decreased plasma insulin level seen in these animals, an
enhanced insulin sensitivity condition may occur as will be
discussed below. An inverse relationship between plasma
insulin and adipose tissue lipolytic activity has also been
reported in NZO mice.42
In vitro studies using epididymal adipose tissues from 3
month old MSG-rats have found both basal and isoproter-
enol stimulated lipolytic response diminished.12,13 A
decreased tissue NE content and slow rates of NE turnover
have been reported in both the interscapular brown adipose
tissue (IBAT) of 3-weeks old pre-obese MSG mice43,44 and
white adipose tissue of 12 – 18 week old MSG rats.13,45 It may
therefore be possible that in our 1 month old MSG-rats, the
sympathetic regulation of lumbar adipose tissue activity is
impaired, being then responsible for the modified lipolytic
response to the epinephrine stimulus.
The present findings clearly show that adipose tissue of
1 month old MSG rats have an enhanced capability to reutilize
the lipolytic released glycerol for both fatty acids and glycer-
ide glycerol synthesis, the effect being specially manifested
when pieces of tissue were incubated in the presence of
epinephrine and=or in the presence of glucose. This enhanced
conversion of labeled glycerol to lipids under conditions
Figure 1 HSL activity and mRNA in adipose tissue of 1 month old neonatally MSG treated rats. Total HSL, activity (left side of the figure) and HSL mRNA
(right side of the figure) were measured as described in the Materials and methods section. The insert of the figure shows a representative autoradiogram
of hybridation of cDNA probes for HSL mRNA and a photograph of the gel showing the band corresponding to the 28S rRNA. Statistical comparison
between the two groups are shown by asterisks: * P<0.05, *** P<0.001. n6 rats=group.
Table 5 Incorporation of U-14C-glucose into total lipids and 14CO2,
3H-
2-deoxy-D-Glucose uptake and GLUT4 content in adipocytes from
lumbar adipose tissue of 1 month-old MSG-treated rats
Control MSG
14C-lipid from 14C-glucose
(pmoles h71 1075 cells)
42.24.7 115.723.1*
14CO2 production from
14C-glucose
(pmoles h71 1075 cells)
22.93.4 59.614.8*
3H-2-deoxy-D-Glucose uptake
(pmoles 1075 cells 3 min)
53.85.1 151.612.0*
Plasma membrane GLUT4 (PM)
(cpm=mg protein)
33.74.2 36.85.6
Microsomal GLUT4 (M)
(cpm=mg protein)
54.92.1 39.42.28*
Index of cellular GLUT4
translocation (PM 100=(PMM))
46.64.6 63.76.4*
*P<0.01 compared to controls.
n 6 rats=group.
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where the amount of cold glycerol in the medium did not
differ between the two groups, indicates that the effect is not
an artefact due to the different dilution of the tracer. Utiliza-
tion of glycerol by adipose tissue is normally very low16,17 due
to its low glycerolkinase activity,18 but it may be acutely
modulated by insulin, catecholamines, glucose and metabolic
inhibitor agents.28,46 – 48 Besides, it has also been shown that
glycerolkinase activity is enhanced in certain types of obe-
sity,19 and therefore, it may represent a key step in the
capability of the tissue to reesterify fatty acids, controling its
balance between triglyceride breakdown and accumulation.
The enhanced capability of adipose tissue from our neonatal
MSG-rats to reutilize the lipolytic released glycerol, may there-
fore contribute to their development of obesity.
Besides the decreased adipose tissue lipolytic activity and
enhanced glycerol reutilization, an increase in glucose
uptake and its conversion into lipids could also be contribut-
ing to the enhanced adipocyte lipid content present in the
1 month old MSG-rats, and this change could be a conse-
quence of the increased index of cellular GLUT4 transloca-
tion seen here in their adipocytes. This finding agrees with
the fact that in adipocytes of pre-obese fatty rats both GLUT4
mRNA and protein levels have been shown to be more than
twice those of controls,49 whereas a decreased glucose trans-
porter (GLUT4) content was found in epididymal adipose
tissue of adult obese aurothioglucose and MSG-treated
mice15 and MSG rats.50 Although not directly measured in
vivo, the decrease in both glycemia and insulinemia, the
enhanced incorporation of U-14C-glucose into lipids and
the increased 3H-2-deoxy-D-glucose uptake as well as the
increased number of receptors found here in adipocytes of
1 month old MSG-rats would suggest an enhanced insulin
sensitivity condition. The decreased HSL activity and mRNA
expression, found in adipose tissue of our MSG-treated rats
also supports this conclusion, since conditions of hyperinsu-
linemia and decreased insulin sensitivity, like that taking
place during late pregnancy, are known to have the opposite
effect on these variables.21 Enhanced insulin sensitivity in 1
month old MSG-rats may occur despite hyperinsulinemia
and insulin resistance being reported in adult MSG-rats,51
since a similar transient insulin hypersensitivity followed by
decreased insulin responsiveness in white adipose tissue has
been reported to occur in both VMH-induced obesity52 and
obese Zucker rats.53
The present findings do not allow us to establish the order
of the different factors contributing to the later development
of obesity in the MSG rats. The results reported here however
indicate that the enhanced insulin sensitivity present in 1
month old MSG-rats, could contribute, and even be the
inductive factor of several of the metabolic alterations
taking place in their adipose tissue, which clearly must
contribute to the development of obesity: a decreased lipo-
lytic activity and an enhanced glucose uptake, lipogenesis
and glycerol reutilization, which would disturb the normal
balance between the breakdown of fat depots and the accu-
mulation in favor of the latter.
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